S&P 500

6.021,63

0,57%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

VIVE

Viveve Medical (VIVE)

Viveve Medical Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VIVE

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
06/02/2023	22h03	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:VIVE	Viveve Medical Inc
31/01/2023	12h08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h07	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h05	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h05	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h05	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
27/01/2023	12h04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:VIVE	Viveve Medical Inc
17/01/2023	12h21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VIVE	Viveve Medical Inc
05/01/2023	22h05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VIVE	Viveve Medical Inc
05/01/2023	22h05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VIVE	Viveve Medical Inc
05/01/2023	22h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VIVE	Viveve Medical Inc
05/01/2023	22h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VIVE	Viveve Medical Inc
05/01/2023	22h03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VIVE	Viveve Medical Inc
05/01/2023	22h03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VIVE	Viveve Medical Inc
06/12/2022	22h37	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:VIVE	Viveve Medical Inc
02/12/2022	22h13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VIVE	Viveve Medical Inc
01/12/2022	14h30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VIVE	Viveve Medical Inc
23/11/2022	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VIVE	Viveve Medical Inc
14/11/2022	23h44	Edgar (US Regulatory)	Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)	NASDAQ:VIVE	Viveve Medical Inc
10/11/2022	23h15	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:VIVE	Viveve Medical Inc
10/11/2022	22h14	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VIVE	Viveve Medical Inc